Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> GILEAD SCIENCES Latest News

SEP 17, 2014 - TheStreet

A Must Read - Share

3 Huge Stocks on Traders' Radars: SHLD, PFE, GILD

aBALTIMORE (Stockpickr) --aPut down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating investment ideas. Instead, let the crowd do it for you. Read More: 5 Stocks With Big Insider Buying From hedge funds to individual investors, scores of market participants are turning to social media to figure out which ...

Tags: 3 Huge Stocks on Traders' Radars: SHLD, PFE, GILD,  Gilead Sciences Latest News

SEP 17, 2014 - Wall Street Journal

A Must Read - Share

Gilead Cancer Treatment Fails

Gilead Sciences said Wednesday that results from a Phase 2 study showed its treatment simtuzumab didn't provide a clinical benefit in advanced pancreatic cancer patients.

Tags: Gilead Cancer Treatment Fails,  Gilead Sciences Latest News

SEP 16, 2014 - Philadelphia Inquirer

A Must Read - Share

Gilead strikes deal on cheaper version of hepatitis C drug

The shifting global pharmaceutical industry shifted a bit more Monday when Gilead Sciences said it struck a deal with seven India-based generic drugmakers, including a subsidiary of Pittsburgh-based Mylan Inc., to make and sell cheaper versions of Gilead's $1,000-per-pill hepatitis C medication, Sovaldi, in 91 developing nations.

Tags: Gilead strikes deal on cheaper version of hepatitis C drug,  Gilead Sciences Latest News

SEP 16, 2014 - TheStreet

A Must Read - Share

'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks

NEW YORK (TheStreet) -- The Dow Jones Industrial Average posted a gain on Monday, closing higher by 0.26%. However, the Nasdaq slid 1.07%.a On CNBC's "Fast Money" TV show, Guy Adami, managing director of stockmonster.com, notedathe iShares Russell 2000 ETF fell lower than the Nasdaq, down 1.15%. He said the exchange-traded fundais likely headed to $108. Tim Seymour, managing partner ...

Tags: 'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks,  Gilead Sciences Latest News

SEP 15, 2014 - Wall Street Journal

A Must Read - Share

Gilead to Allow Cheaper Hepatitis C Drug in Developing Countries

Gilead Sciences said it will allow generic drug makers to make cheaper versions of Sovaldi, its $1,000-a-day hepatitis C pill, to sell in developing countries.

Tags: Gilead to Allow Cheaper Hepatitis C Drug in Developing Countries,  Gilead Sciences Latest News